Slides on Clinical Impact of New Rheumatoid Arthritis Findings From APLAR 2019, JCR 2019, and EULAR 2019

Experts discussion of recent efficacy and safety data on JAK inhibitors in managing RA, from Clinical Care Options (CCO)

Stanley B. Cohen, MD Janet Pope, MD, MPH, FRCPC Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Released: January 10, 2023 Expired: January 9, 2024

Drs. Stanley Cohen and Janet Pope on the latest clinical trials and real-world evidence regarding JAK inhibitor efficacy from Clinical Care Options (CCO)

Vivian P. Bykerk, MD, FRCPC Stanley B. Cohen, MD Janet Pope, MD, MPH, FRCPC Vibeke Strand, MD, MACR, FACP Released: January 9, 2023

Clinical Care Options (CCO): infectious diseases physician on use of postexposure chemoprophylaxis for patients with rheumatologic disorders who are at high-risk for influenza complications

Tracy Zivin-Tutela, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Released: December 9, 2022 Expired: December 8, 2023

Clinical Care Options (CCO) presents expert faculty discussing options for the treatment and care of patients with rheumatic disease during flu season.

Cassandra Calabrese, DO Released: December 2, 2022